These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3325658)
1. [Cyclosporine in allogeneic bone marrow transplantation in children]. Kojima S; Fukuda M; Horibe K; Matsuyama K Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658 [No Abstract] [Full Text] [Related]
2. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease. Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942 [No Abstract] [Full Text] [Related]
3. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation. Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247 [No Abstract] [Full Text] [Related]
4. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937 [TBL] [Abstract][Full Text] [Related]
5. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation]. Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783 [No Abstract] [Full Text] [Related]
6. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia. Bacigalupo A; Frassoni F; van Lint MT; Raffo MR; Vitale V; Corbetta G; Chierichetti S; Marmont AM Exp Hematol; 1985 May; 13(4):244-8. PubMed ID: 3886417 [TBL] [Abstract][Full Text] [Related]
7. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation. Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659 [No Abstract] [Full Text] [Related]
8. [Bone marrow transplantation in pediatric patients: review of progress]. Inoue S Gan To Kagaku Ryoho; 1987 Apr; 14(4):994-1003. PubMed ID: 3551848 [No Abstract] [Full Text] [Related]
9. Acute graft-versus-host disease after allogeneic bone marrow transplantation. Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Trigg ME; Billing R; Sondel PM; Exten R; Hong R; Bozdech MJ; Horowitz SD; Finlay JL; Moen R; Longo W Cancer Treat Rep; 1985 Apr; 69(4):377-86. PubMed ID: 3888387 [TBL] [Abstract][Full Text] [Related]
11. [Low early mortality after allogeneic bone marrow transplantation thanks to rigorous sterility measures, modified whole body irradiation, cyclosporin A and antiviral precautions]. Gmür J; Burger J; Frick P Schweiz Med Wochenschr; 1985 Oct; 115(43):1524-5. PubMed ID: 3001930 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation. Ramsay NK Trans Assoc Life Insur Med Dir Am; 1988; 71():162-73. PubMed ID: 3285567 [No Abstract] [Full Text] [Related]
13. Treatment of leukemia and aplastic anemia with histocompatible allogeneic bone marrow transplantation. A review. Graw RG; Herzig GP Schweiz Med Wochenschr; 1972 Nov; 102(44):1573-81. PubMed ID: 4405057 [No Abstract] [Full Text] [Related]
14. Bone marrow transplantation in pediatrics. Krivit W; Ramsay NK; Woods W; Nesbit M; Filipovich AH; Kim T; Kersey J Adv Pediatr; 1983; 30():549-93. PubMed ID: 6369944 [No Abstract] [Full Text] [Related]
15. Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients. Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M Transplant Proc; 1994 Jun; 26(3):1821-2. PubMed ID: 8030154 [No Abstract] [Full Text] [Related]
16. Bone marrow transplantation in children. Kato S; Yabe H; Yabe M; Hoshi N; Kimura M; Noguchi K; Arimori S; Tsuji K; Mori T; Yokoyama S Tokai J Exp Clin Med; 1986; 11 Suppl():43-7. PubMed ID: 2837836 [No Abstract] [Full Text] [Related]
17. Prevention of graft versus host disease following allogeneic bone marrow transplantation. Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738 [No Abstract] [Full Text] [Related]
18. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)]. Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471 [No Abstract] [Full Text] [Related]
19. Bone marrow transplantation in malignant diseases and aplastic anemia. Zander AR; Dicke KA Tex Med; 1984 Jul; 80(7):40-2. PubMed ID: 6379970 [No Abstract] [Full Text] [Related]
20. Allogeneic bone marrow transplantation in 25 patients with severe aplastic anemia. Kojima S; Matsuyama K; Kodera Y; Hirabayashi N; Morishima Y; Iwamura H; Naito K; Nakaide Y; Yokomaku S; Yamada H Nihon Ketsueki Gakkai Zasshi; 1988 Jul; 51(4):705-14. PubMed ID: 3059741 [No Abstract] [Full Text] [Related] [Next] [New Search]